ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Current Value
$238.731 Year Return
Current Value
$238.731 Year Return
Market Cap
$34.96B
P/E Ratio
31.57
1Y Stock Return
56.12%
1Y Revenue Growth
9.88%
Dividend Yield
1.00%
Price to Book
6.7
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EXPO | 40.27% | $4.82B | +20.93% | 1.16% |
ULH | 38.58% | $1.25B | +97.14% | 0.88% |
APPF | 34.60% | $8.30B | +16.30% | 0.00% |
ROG | 33.87% | $1.88B | -23.03% | 0.00% |
DLR | 32.27% | $62.12B | +37.49% | 2.63% |
ABT | 30.13% | $203.16B | +14.93% | 1.88% |
ORC | 29.96% | $615.55M | +6.95% | 18.46% |
AN | 29.67% | $6.53B | +24.16% | 0.00% |
PAG | 29.61% | $10.63B | +4.43% | 2.59% |
LOCO | 29.58% | $361.37M | +39.70% | 0.00% |
RPM | 29.54% | $17.37B | +32.07% | 1.41% |
ABG | 29.45% | $4.91B | +21.76% | 0.00% |
SNN | 29.37% | $11.12B | -0.04% | 2.98% |
GMAB | 29.36% | $13.02B | -33.87% | 0.00% |
PEN | 29.34% | $9.10B | +2.99% | 0.00% |
WAT | 29.32% | $20.47B | +25.51% | 0.00% |
IONQ | 29.31% | $6.04B | +126.93% | 0.00% |
SUNS | 29.27% | $105.89M | +35.31% | 1.37% |
PODD | 29.20% | $18.38B | +44.49% | 0.00% |
TFX | 29.11% | $8.97B | -10.85% | 0.71% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CLMT | 0.01% | $1.79B | +35.14% | 0.00% |
EG | -0.05% | $15.92B | -8.98% | 2.02% |
SIGI | 0.08% | $5.90B | -4.96% | 1.47% |
TRMD | -0.10% | $2.31B | -24.74% | 25.24% |
KOS | -0.10% | $1.85B | -42.25% | 0.00% |
PRT | -0.11% | $48.72M | -16.56% | 10.33% |
APA | 0.13% | $8.11B | -40.14% | 4.54% |
KNOP | -0.21% | $210.40M | +11.75% | 1.68% |
GRAL | 0.23% | $459.22M | -13.00% | 0.00% |
CRVO | -0.23% | $83.20M | +2.86% | 0.00% |
CRTO | -0.25% | $2.10B | +58.23% | 0.00% |
EC | -0.25% | $16.55B | -34.59% | 29.79% |
PAA | 0.27% | $12.26B | +12.02% | 7.26% |
HE | -0.29% | $1.82B | -17.47% | 0.00% |
MUR | 0.29% | $4.74B | -23.99% | 3.70% |
DVAX | 0.30% | $1.58B | -11.37% | 0.00% |
CF | -0.33% | $15.23B | +14.45% | 2.28% |
VIST | -0.33% | $4.75B | +67.10% | 0.00% |
COUR | -0.35% | $1.08B | -64.26% | 0.00% |
WRB | -0.39% | $22.94B | +29.98% | 0.69% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KNSL | -28.97% | $10.93B | +29.38% | 0.13% |
TNET | -27.86% | $4.41B | -19.81% | 0.84% |
PRPO | -14.83% | $9.10M | -13.65% | 0.00% |
ALNY | -14.70% | $30.22B | +43.13% | 0.00% |
WKC | -14.07% | $1.61B | +30.46% | 2.33% |
HIG | -13.94% | $33.87B | +51.09% | 1.60% |
AON | -13.78% | $82.00B | +16.33% | 0.70% |
LPTH | -13.74% | $62.27M | +33.05% | 0.00% |
ARLP | -13.74% | $3.54B | +26.77% | 10.11% |
BYD | -13.24% | $6.32B | +21.62% | 0.94% |
VIRT | -12.21% | $3.17B | +110.38% | 2.60% |
TS | -11.91% | $20.74B | +8.26% | 4.72% |
XOM | -11.32% | $521.39B | +13.56% | 3.22% |
QUAD | -11.26% | $366.66M | +43.76% | 2.84% |
TPST | -11.24% | $37.75M | -77.59% | 0.00% |
HUSA | -11.19% | $16.69M | -11.56% | 0.00% |
TBBK | -11.19% | $2.63B | +42.88% | 0.00% |
BG | -10.71% | $12.50B | -17.29% | 3.02% |
NNE | -10.47% | $833.66M | +531.50% | 0.00% |
PULM | -10.36% | $19.83M | +202.98% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHI | 46.72% | $4.91B | 0.4% |
XHE | 41.97% | $213.41M | 0.35% |
RSPH | 36.15% | $885.96M | 0.4% |
HNDL | 35.17% | $780.63M | 0.97% |
JHML | 34.82% | $979.36M | 0.29% |
UDIV | 34.70% | $38.94M | 0.06% |
BSJS | 34.20% | $293.93M | 0.42% |
SCHK | 34.00% | $3.96B | 0.05% |
PFUT | 33.70% | $326.69M | 0.64% |
VHT | 33.52% | $17.06B | 0.1% |
AOK | 33.51% | $617.23M | 0.15% |
ARKX | 33.50% | $249.95M | 0.75% |
HYDB | 33.45% | $1.07B | 0.35% |
KOMP | 33.39% | $2.09B | 0.2% |
VO | 33.39% | $73.70B | 0.04% |
FHLC | 33.24% | $2.73B | 0.084% |
AOM | 33.24% | $1.43B | 0.15% |
SIZE | 33.23% | $329.63M | 0.15% |
SRVR | 32.85% | $448.44M | 0.55% |
SPYX | 32.83% | $2.03B | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBE | -0.01% | $50.13M | 0.77% |
FMF | 0.29% | $244.61M | 0.95% |
IEO | 0.29% | $658.25M | 0.4% |
IBDP | 0.62% | $2.11B | 0.1% |
DBO | -0.72% | $217.57M | 0.77% |
KRBN | 1.12% | $242.47M | 0.85% |
TBIL | 1.13% | $4.38B | 0.15% |
JBBB | -1.33% | $1.26B | 0.49% |
MSOS | 1.33% | $632.80M | 0.83% |
IBTE | 1.52% | $1.70B | 0.07% |
VDE | 1.79% | $8.33B | 0.1% |
CANE | -1.95% | $17.72M | 0.29% |
IYE | 2.01% | $1.35B | 0.39% |
XBIL | -2.15% | $637.70M | 0.15% |
DBA | -2.16% | $755.88M | 0.93% |
FENY | 2.22% | $1.64B | 0.084% |
JUCY | 2.27% | $324.29M | 0.6% |
XLE | 2.28% | $37.90B | 0.09% |
FTXN | 2.39% | $179.41M | 0.6% |
KCCA | -2.46% | $220.51M | 0.87% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -24.16% | $388.04M | 1.43% |
VIXY | -14.73% | $195.31M | 0.85% |
CTA | -14.01% | $350.27M | 0.78% |
USDU | -13.16% | $201.97M | 0.5% |
UUP | -13.00% | $309.25M | 0.77% |
EQLS | -10.62% | $76.08M | 1% |
HIGH | -8.81% | $302.78M | 0.51% |
BILZ | -7.78% | $563.02M | 0.14% |
UNG | -7.20% | $908.80M | 1.06% |
DRLL | -6.57% | $336.91M | 0.41% |
TAIL | -6.36% | $67.98M | 0.59% |
BOXX | -4.13% | $4.43B | 0.1949% |
KMLM | -3.46% | $353.87M | 0.9% |
MINT | -3.37% | $11.62B | 0.35% |
TPMN | -2.67% | $40.60M | 0.65% |
AGZD | -2.66% | $142.76M | 0.23% |
KCCA | -2.46% | $220.51M | 0.87% |
DBA | -2.16% | $755.88M | 0.93% |
XBIL | -2.15% | $637.70M | 0.15% |
CANE | -1.95% | $17.72M | 0.29% |
Yahoo
MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
Yahoo
Zimmer Biomet gets CE Mark Certification for Persona Revision Knee System, followed by the successful introduction in the United States and other markets.
Yahoo
Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.
Yahoo
ResMed shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.
MarketWatch
ResMed Inc. stock rises Monday, outperforms market
Yahoo
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.